Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory diseases
Pharma
GSK posts COPD win for Nucala as rival nears possible approval
GSK said Nucala and inhaled maintenance therapy lowered the annualized rate of moderate or severe exacerbations among COPD patients for up to 2 years.
Fraiser Kansteiner
Sep 6, 2024 9:40am
Jane Seymour backs Insmed's push to tackle gender and age biases
Mar 5, 2024 6:41am
CDC ad campaign seeks to stir emotions to drive vaccine uptake
Dec 13, 2023 8:03am
Respiratory patient groups decry pricing, access to lung meds
Jul 24, 2023 7:34am
JPM: Novartis CEO refutes respiratory, eye drug sell-off report
Jan 9, 2023 4:56pm
Novartis targets eye, respiratory units for sell-offs: Bloomberg
Nov 16, 2022 10:48am
